Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade

被引：0
|
作者：
Bohm, M
Lippoldt, A
Wienen, W
Ganten, D
Bader, M
机构：
[1] MAX DELBRUCK CTR MOL MED, D-13125 BERLIN, GERMANY
[2] DR KARL THOMAE GMBH, PHARMA RES A, D-7950 BIBERACH, GERMANY
来源：
MOLECULAR AND CELLULAR BIOCHEMISTRY | 1996年 / 164卷
关键词：
heart hypertrophy; transgenic rats; hypertension; angiotensin II;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
TGR(mREN2)27 is a transgenic rat harboring the murine Ren-2 gene and exhibit fulminant hypertension and marked heart hypertrophy. In order to study the role of angiotensin II in the increase of cardiac mass, these animals were treated with antihypertensive and non-antihypertensive doses of the angiotensin II receptor AT(1) antagonist Telmisartan for 9 weeks. All doses led to significant reductions of heart hypertrophy detected by the evaluation of the diameter of cardiac muscle bundles, We conclude from this study that cardiac hypertrophy in TGR(mREN2)27 is characterized by an increased volume of cardiomyocytes and an unchanged amount of fibrous tissue and that angiotensin II plays an important role in the mechanisms leading to this phenotype.
引用
收藏
页码：217 / 221
页数：5
相关论文
共 50 条
  • [21] ANGIOTENSIN-II RECEPTOR BLOCKADE IN TCR(MREN2)27 - EFFECTS OF RENIN-ANGIOTENSIN-SYSTEM GENE-EXPRESSION AND CARDIOVASCULAR FUNCTIONS
    BOHM, M
    LEE, MA
    KREUTZ, R
    KIM, S
    SCHINKE, M
    DJAVIDANI, B
    WAGNER, J
    KALING, M
    WIENEN, W
    BADER, M
    GANTEN, D
    JOURNAL OF HYPERTENSION, 1995, 13 (08) : 891 - 899
  • [22] (Pro)renin Receptor Inhibition in Diabetic Transgenic mREN2 Rats (TGR(mREN2)27) Upregulates Endothelium-Derived Contractile Factors
    Batenburg, Wendy W.
    van den Heuvel, Mieke
    van Esch, Joep H.
    van Veghel, Richard
    Danser, A. H.
    HYPERTENSION, 2011, 58 (05) : E71 - E72
  • [23] Changes in VSMC phenotypes in ang II-dependent hypertension of TGR (mREN2) 27 (Tgr) transgenic rats
    Rossi, GPP
    Sartore, S
    Colonna, S
    Sacchetto, A
    Rizzoni, D
    Mazzocchi, G
    Belloni, AS
    Nussdorfer, GG
    Pessina, AC
    HYPERTENSION, 2000, 36 (04) : 688 - 688
  • [24] Activation of the cardiac endothelin-system parallels the transition from compensatory hypertrophy to heart failure in TGR(mRen2)27 rats
    Rothermund, L
    Leggewie, S
    Hocher, B
    Orzechowski, HD
    Pinto, YM
    Krutz, R
    Paul, M
    HYPERTENSION, 1999, 34 (04) : 698 - 698
  • [25] Echocardiographic evaluation of the TGR(mRen2)27 transgenic rat reveals severe ventricular hypertrophy and pericardial effusion
    Numan, MT
    Byrne, BJ
    Gelband, CH
    Pachori, A
    Katovich, MJ
    Ganten, D
    Fenario, C
    Raizada, MK
    PEDIATRIC RESEARCH, 1999, 45 (04) : 28A - 28A
  • [26] Echocardiographic Evaluation of the TGR(mRen2)27 Transgenic Rat Reveals Severe Ventricular Hypertrophy and Pericardial Effusion
    Mohammed T Numan
    Barry J Byrne
    Creg H Gelband
    Alok Pachori
    Michael J Katovich
    Detlev Ganten
    Carlos Fenario
    Mohan K Raizada
    Pediatric Research, 1999, 45 : 28 - 28
  • [27] Renoprotective effects of specific MAP-kinase blockade in homozygous TGR(mRen2)27 rats.
    de Borst, MH
    Navis, G
    de Boer, RA
    Vis, LM
    van Gilst, WH
    van Goor, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 339A - 339A
  • [28] Alamandine Improves Cardiac Post-Ischemic Function in Isolated Hearts of TGR(mREN2)27
    Almeida, Jonathas F.
    Santos, Robson A.
    HYPERTENSION, 2016, 68
  • [29] Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats, TGR(mREN2)27
    Peters, J
    Hilgers, KF
    MaserGluth, C
    Kreutz, R
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1996, 18 (07) : 933 - 948
  • [30] Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2) 27 rats
    Jacke, K
    Witte, K
    Huser, L
    Behrends, S
    Lemmer, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 403 (1-2) : 27 - 35
12345